Japan's DNP establishes second overseas R&D base in IIT Hyderabad, India
On March 23, 2026, Japan’s Dai Nippon Printing (DNP) announced the establishment of a new research and development (R&D) base at the Indian Institute of Technology Hyderabad (IIT-H) in Telangana, India. This initiative marks DNP’s second overseas R&D facility, following the opening of its first base in the Netherlands in September 2025.
Strategic Objectives
The new R&D base aims to strengthen DNP’s global R&D strategy, particularly focusing on the mobility and medical healthcare sectors. By collaborating with IIT-H, a premier science and engineering university, DNP seeks to leverage the institution’s expertise in human resources and research capabilities, combined with DNP’s technological strengths.
Location and Facilities
The DNP R&D facility will be located within the Technology Research Park (TRP) on the IIT-H campus. This corporate collaboration space is designed to foster partnerships between academia and industry, facilitating innovative research and development.
Focus Areas of Research
DNP’s joint research with IIT-H will primarily focus on:
- Development of synthesis routes for active pharmaceutical ingredients (APIs)
- Advancements in mobility technologies
- Innovations in medical healthcare
Advancements in Pharmaceutical Development
One of the key objectives of the new R&D base is to enhance the development of APIs. DNP plans to utilize the expertise of DNP Fine Chemicals Utsunomiya, a subsidiary of DNP, which specializes in precision organic chemical synthesis and process development. This collaboration will encompass the entire process from synthesis route design to prototyping, evaluation, and mass production.
Market Expansion Goals
With the establishment of this R&D base, DNP aims to position India as a critical global development hub for APIs. The company plans to commercialize its R&D outcomes and expand its sales efforts in India and other international markets.
Significance of the Collaboration
This collaboration between DNP and IIT-H is significant for several reasons:
- Innovation Boost: The partnership is expected to drive innovation in both mobility and healthcare sectors, contributing to advancements in technology and product development.
- Economic Impact: By establishing a presence in India, DNP is likely to create jobs and foster economic growth in the region.
- Global Integration: This initiative reflects a broader trend of global integration in research and development, where companies leverage international partnerships to enhance their capabilities.
Future Prospects
Looking ahead, DNP envisions a robust future for its operations in India. The company aims to not only enhance its R&D capabilities but also to contribute to the overall growth of the pharmaceutical and healthcare sectors in the region.
Conclusion
The establishment of DNP’s second overseas R&D base at IIT Hyderabad represents a strategic move to enhance its global R&D capabilities while tapping into the growing markets of India and Africa. This collaboration is expected to yield significant advancements in pharmaceutical development and medical technologies, ultimately benefiting both DNP and the local economy.
Note: The information presented in this article is based on the latest announcements and developments as of March 2026.
